Helminth-Associated Altered Mentation: Evaluation and Management
Altered mental status from helminth infection requires immediate neuroimaging (MRI with contrast plus non-contrast CT), CSF analysis with eosinophil count, serology, and urgent specialist consultation—with neurocysticercosis, neuroschistosomiasis, and eosinophilic meningitis being the most critical diagnoses to exclude.
Diagnostic Approach
Immediate Evaluation
The evaluation must be algorithmically structured based on the clinical presentation:
Neuroimaging First:
- Obtain both brain MRI with contrast AND non-contrast CT scan to properly classify the disease 1
- MRI identifies cystic lesions, ring enhancement, edema, and spinal cord involvement
- CT detects calcifications and acute hydrocephalus
Laboratory Workup:
- Peripheral blood eosinophil count (often markedly elevated >5 × 10⁹/L in acute helminth CNS disease) 2
- CSF examination: cell count with differential (eosinophilia present in <50% of cases), protein, glucose 3
- Serology: enzyme-linked immunotransfer blot for neurocysticercosis (avoid crude antigen ELISAs due to poor sensitivity/specificity) 4
- Stool microscopy for all household contacts if neurocysticercosis suspected 2
Critical History Elements:
- Travel to endemic regions (Africa for schistosomiasis, Latin America/Asia for neurocysticercosis, Southeast Asia for angiostrongyliasis/gnathostomiasis)
- Freshwater swimming exposure 2-8 weeks prior (schistosomiasis)
- Consumption of undercooked pork (neurocysticercosis), fish, frogs, snakes (gnathostomiasis), or snails/prawns (angiostrongyliasis)
- Contact with raccoon feces (Baylisascaris)
- Passage of tapeworm segments 3, 4
Fundoscopic Examination:
- Mandatory before initiating anthelmintic therapy to detect ocular cysticercosis 1
Specific Diagnoses and Management
Neurocysticercosis (Most Common)
Clinical Presentation: Seizures (most common), headache, obstructive hydrocephalus, focal neurological deficits; fever typically absent 2, 4
Treatment Algorithm:
- For 1-2 viable parenchymal cysts: Albendazole 15 mg/kg/day (max 1200 mg/day) divided twice daily for 10-14 days with food PLUS corticosteroids 1, 4
- For >2 cysts: Combination albendazole PLUS praziquantel PLUS corticosteroids 2
- Praziquantel dosing: 40 mg/kg for parenchymal disease; 60 mg/kg in two divided doses for ventricular disease 2
- Corticosteroid protocol: Start dexamethasone one day BEFORE praziquantel, reduce after 7 days (longer if marked edema or clinical deterioration) 2
- For untreated hydrocephalus or diffuse cerebral edema: Manage elevated intracranial pressure ALONE—do NOT give antiparasitic treatment 1
Critical Pitfall: Dexamethasone reduces praziquantel levels through increased metabolism; monitor closely 2
Neuroschistosomiasis
Clinical Presentation:
- Acute myelopathy (S. mansoni/S. haematobium): rapidly progressive transverse myelitis with lower limb pain, motor dysfunction, bladder/bowel paralysis 3, 2
- Cerebral disease (S. japonicum): seizures, motor/sensory deficits, cerebellar syndrome 3, 2
- Acute Katayama syndrome with neurological symptoms: encephalitis, altered consciousness, headache, seizures 3
Treatment:
- Praziquantel 40 mg/kg twice daily for 5 days PLUS dexamethasone 4 mg four times daily, reducing after 7 days over 2-6 weeks 3
- For acute Katayama with neurological symptoms: Treat with corticosteroids ALONE initially to avoid neurological complications; delay praziquantel 3
Important Note: Serology and stool/urine microscopy often negative; peripheral eosinophilia may be absent; CSF eosinophilia in <50% 3
Eosinophilic Meningitis
Angiostrongylus cantonensis (Rat Lungworm):
- Severe acute headache, meningism, visual disturbance, cranial nerve palsies
- Treatment: Prednisolone 60 mg once daily for 14 days (mainstay) PLUS albendazole 15 mg/kg/day for 14 days 3, 2
- Therapeutic lumbar punctures may be necessary
- CT/MRI often normal despite severe symptoms 3
Gnathostomiasis:
- Myeloencephalitis with headache, radicular pain, later paralysis and bladder incontinence
- Treatment: Albendazole or ivermectin 5
Toxocariasis:
- Eosinophilic meningo-encephalitis
- Treatment: Albendazole for 3-4 weeks PLUS corticosteroids; repeat anthelmintic therapy may be required 2
Baylisascaris (Raccoon Roundworm)
Presentation: Severe CNS dysfunction ranging to coma and death, particularly in children Treatment: Albendazole PLUS diethylcarbamazine PLUS corticosteroids 5
Pre-Treatment Screening Requirements
Before Corticosteroids:
- Screen for latent tuberculosis 1
- Exclude or empirically treat Strongyloides stercoralis (risk of hyperinfection syndrome with steroids) 1, 2
- Empirical treatment: Ivermectin 200 μg/kg on days 1,2,15, and 16 if immunocompromised 2
Before Ivermectin:
- Exclude Loa loa in patients from endemic regions (Central/West Africa) to prevent severe reactions 2
Monitoring During Treatment
For albendazole >14 days:
- Monitor for hepatotoxicity and leukopenia 1
- Blood glucose monitoring with corticosteroids
- Consider proton pump inhibitors for gastric protection 2
Follow-up imaging:
- Repeat MRI at least every 6 months until resolution of cystic component 1
Key Clinical Pitfalls
- Do not delay corticosteroids when starting anthelmintics for CNS helminth disease—the inflammatory response to dying parasites can cause catastrophic neurological deterioration
- Never give anthelmintics for hydrocephalus or diffuse cerebral edema without first managing elevated intracranial pressure
- Strongyloides hyperinfection with corticosteroids is potentially fatal—always exclude or treat empirically before steroids
- Serology may be negative in acute neuroschistosomiasis—trial of treatment warranted with compatible clinical picture 3
- CSF eosinophilia is absent in >50% of helminth CNS infections—do not rely on this finding 3
When Organism Not Identified
If no specific organism identified but helminth CNS infection suspected based on travel history and clinical presentation: